BioCentury | Jul 25, 2005
Clinical News

RC-8800: Phase I started

...to 12 healthy subjects. Rejuvenon Corp. , Houston, Texas Product: RC-8800 Business: Cancer Molecular target: 24-hydroxylase...
BioCentury | May 3, 2004
Company News

University of Wisconsin other research news

...no increase in serum calcium concentration but significantly suppressed parathyroid hormone levels (p<0.05) and induced 24-hydroxylase...
Items per page:
1 - 2 of 2